OUR MISSION

At Bio Conscious Technologies, our team of medical and technology professionals apply leading edge machine learning to revolutionize how the world understands glucose

HIPPA COMPLIANT

HIPPA COMPLIANT

THE DRIVING FORCE

GLUCOSE

GLUCOSE

We understand glucose and are pioneers in using Artificial Intelligence to draw added value from Continuous Glucose Monitoring data

We understand glucose and are pioneers in using Artificial Intelligence to draw added value from Continuous Glucose Monitoring data

We understand glucose and are pioneers in using Artificial Intelligence to draw added value from Continuous Glucose Monitoring data

Understand how glucose metabolism affects human health

Understand how glucose metabolism affects human health

Understand how glucose metabolism affects human health

Create AI-powered solutions needed by clinicians

Create AI-powered solutions needed by clinicians

Create AI-powered solutions needed by clinicians

Invest advanced R&D to better understand dysglycemia

Invest advanced R&D to better understand dysglycemia

Invest advanced R&D to better understand dysglycemia

OUR SCIENCE / OUR PRODUCTS

We have developed a multi-layered approach driven by three levels of AI. Each level brings us closer to transforming care, empowering individuals, and enabling healthcare providers to offer precision-driven, personalized care.

We have developed a multi-layered approach driven by three levels of AI. Each level brings us closer to transforming care, empowering individuals, and enabling healthcare providers to offer precision-driven, personalized care.

We have developed a multi-layered approach driven by three levels of AI. Each level brings us closer to transforming care, empowering individuals, and enabling healthcare providers to offer precision-driven, personalized care.

Level 1 AI

Level 1 AI

Empowers proactive diabetes management through three pillars

Empowers proactive diabetes management through three pillars

PLAN

Forecasting future glucose events up to 12 hours ahead, enabling clinicians to proactively inform patients of potential risks before they manifest.

Forecasting future glucose events up to 12 hours ahead, enabling clinicians to proactively inform patients of potential risks before they manifest.

PREPARE

We empower patients to take control of their diabetes management, helping them prevent complications through informed decision-making

We empower patients to take control of their diabetes management, helping them prevent complications through informed decision-making

PROTECT

Patients are armed with critical knowledge about potential high-risk complications, allowing them to better manage their health

Patients are armed with critical knowledge about potential high-risk complications, allowing them to better manage their health


Level 2 AI

Level 2 AI

Automated Remote Patient Monitoring

Automated Remote Patient Monitoring

OUR PRODUCT

Endobits

Endobits

Our Endobits enterprise software harnesses the power of artificial intelligence to transform diabetes care in clinical settings

Our Endobits enterprise software harnesses the power of artificial intelligence to transform diabetes care in clinical settings

Forecasts diabetes events, enabling clinicians and patients to take preventive actions

AI-powered decision support to assist clinicians

Compatible with Abbott & Dexcom

Increases clinical efficiency and reduces per patient operating costs

Integrates with major EHR/EMR systems

AI-powered auto-charting & billing

Our innovative decision support solution provides clinicians with real-time data analytics and actionable insights, enhancing their ability to deliver more precise and personalized diabetes care.

Our innovative decision support solution provides clinicians with real-time data analytics and actionable insights, enhancing their ability to deliver more precise and personalized diabetes care.

Our innovative decision support solution provides clinicians with real-time data analytics and actionable insights, enhancing their ability to deliver more precise and personalized diabetes care.

Curious about how Endobits can elevate your practice?

Discover Endobits

“The integration of CGM data with AI-powered solutions like Endobits represents a significant advancement in diabetes care, By utilizing these technologies, we can provide clinicians with actionable insights in real-time and make diabetes management more efficient and effective”

“The integration of CGM data with AI-powered solutions like Endobits represents a significant advancement in diabetes care, By utilizing these technologies, we can provide clinicians with actionable insights in real-time and make diabetes management more efficient and effective”

Dr. Jerome Fischer

Chief Medical Officer & Renowned Endocrinologist

Level 3 AI

Focusing on holistic health management

We are pioneers at the intersection of Glucose and AI

01

Predict

We began our journey with a consumer-focused app that helped people living with diabetes predict and forecast diabetic events

02

Prioritize

Our Endobits Automated Remote Patient Monitoring solution incorporates technology on par with human capability in analyzing CGM data, providing clinical decision-support to drive better patient outcomes

03

Prevent

Recognizing glucose as the 5th vital sign, our technology will inform the identification, treatment and management of chronic diseases beyond diabetes

PARTNERSHIP: DEXCOM + ENDOBITS

Bioconscious Technologies is proud to announce a strategic API integration with Dexcom, a leader in continuous glucose monitoring (CGM) systems. This collaboration allows Endobits to seamlessly integrate Dexcom’s real-time glucose data, enhancing clinicians’ ability to deliver personalized care and empowering patients with actionable insights to manage their diabetes more effectively.

Read more on Yahoo Finance

BOARD

Telfer Hanson

Chairman & CEO Pathfinder Investments NB

Hartley Stern

Senior Associate at Gerald Pulvermacher & Associates

Norman Betts

Senior Associate at Gerald Pulvermacher & Associates

Radina Giustra

Senior Associate at Gerald Pulvermacher & Associates

Amir Hayeri

Founder & CEO

BOARD

Telfer Hanson

Chairman & CEO Pathfinder Investments NB

Hartley Stern

Senior Associate at Gerald Pulvermacher & Associates

Norman Betts

Senior Associate at Gerald Pulvermacher & Associates

Radina Giustra

Senior Associate at Gerald Pulvermacher & Associates

Amir Hayeri

Founder & CEO

MANAGEMENT

Amir Hayeri

Founder & CEO

Steve Bryan

Chief Operating Officer

Dr. Jerome Fischer

Chief Medical Officer

Neil Clegg

Head of Special Operations

Scott Morris

Founder & CEO

IN THE NEWS

Explore our blog for the latest news in glucose monitoring, tips for managing diabetes, and updates on our technology. Join our community dedicated to health and wellness.

Learn more about Our Timeline

KRPC, Houston

May 9, 2024

How AI is helping to detect pre-diabetes

Dr. Jerome Fischer

CMO, Endocrinologist

Bio Conscious Announces the Integration of GPT 4 LLM Into Its State-of-the-Art Endobits V5 - Creating a Unique Industry-Leading CGM Platform for Diabetes Care


Yahoo Finance

April 25, 2024

LinkedIn

May 1, 2024

Amir Hayeri

Founder & CEO

The endobits algorithm discovered a surprising link between diabetes and dementia

conscious

TECHNOLOGIES

bio

Subscribe to stay up-to-date with the latest news.

Stay connected with us

Read More on Yahoo Finance

Read More on Yahoo Finance

Our Story

Our Story

Our Journey

Our Journey

In The News

In The News

Our Thinking

Our Thinking

Careers

Careers

Let's Get in Touch

Let's Get in Touch

Terms of Service

Terms of Service

Privacy Policy

Privacy Policy

© 2015 - 2024 Bio Conscious Technologies Inc.

⭐️

Connect to Content

Add layers or components to make infinite auto-playing slideshows.

⭐️

Connect to Content

Add layers or components to make infinite auto-playing slideshows.

HIPPA COMPLIANT

HIPPA COMPLIANT

HIPPA COMPLIANT

HIPPA COMPLIANT